Bristol Sees Annual $1.5B in Cost Savings by End of 2025

Seeking Alpha12:53 ET

Xencor Updates on Cash Position as of 2024-end

Seeking Alpha12:51 ET

Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season

Kevin TraversJan 13 10:52 ET

Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal

BenzingaJan 13 10:03 ET

SpringWorks Therapeutics Shares Are Trading Lower Following Q4 and FY24 Financial Results

BenzingaJan 13 09:00 ET

SpringWorks Therapeutics Reported Q4 OGSIVEO Revenue Of $61.5M, Cash Balance Of $461.9M

BenzingaJan 13 06:37 ET